Navigation path

Pharmaceuticals - Community Register

  

List of referrals for human medicinal products

Monovalent and multivalent measles, mumps, rubella and varicella vaccines (live)

Product name: Monovalent and multivalent measles, mumps, rubella and varicella vaccines (live)
Also marketed in the EU under the name(s): Amunovax VIAL, Imovax Oreillons, M-M-R II, Masern-Impfstoff Merieux, Priorix, Priorix-Tetra, Provarivax, R.O.R., R.O.R. VAX, Rouvax, Rubeaten Berna, Rudi Rouvax, Rudixax, Röteln-Impfstoff HDC Merieux, Vaccin Oreillons Aventis Pasteur MSD, Vacuna Antirrubeola GSK, Vacuna Antirrubeola Merieux, Vacuna MSD anti-parotiditis, Varilrix, Varivax
INN: Not available
Indication: Monovalent and multivalent measles, mumps, rubella and/or varicella containing vaccines (MMRV) are live attenuated vaccines which are indicated in vaccination of adults and children against these viruses. Vaccination with these MMRV vaccines is contraindicated in pregnant women and in immunocompromised subjects
Marketing Authorisation Holder: Not applicable

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/03/2013 Referral EMEA/H/A-31/1333 (2013)1256 of 28/02/2013
01/07/2013 Referral (2013)4187 of 27/06/2013